| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4
Address all correspondence and requests for reprints to: Gaétan Guillemette, Ph.D., Department of Pharmacology Faculty of Medicine, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke (Québec), J1H 5N4, Canada. E-mail: Gaetan.Guillemette{at}USherbrooke.ca.
The type 1 receptor for angiotensin II (AT1) is a member of the G protein-coupled receptor family. The presence of a caveolin-binding-like motif (
X
XXXX
XX
where
is an aromatic residue) within the cytoplasmic tail of the AT1 receptor suggests an implication for caveolae in the functionality of this receptor. We constructed a mutant AT1 receptor where each of the aromatic residues in the caveolin-binding-like motif were replaced by alanine (AT1-YFFY/A). Mutation of this motif considerably reduced the plasma membrane expression of the receptor that accumulated in a perinuclear compartment. The agonist-induced internalization rate of the AT1-YFFY/A receptor was also significantly reduced. Finally, the AT1-YFFY/A receptor was poorly activated as indicated by a low agonist-induced production of inositol phosphates. Unexpectedly, the proportion of AT1 receptor found in caveolae was minor under basal conditions and did not increase under stimulated conditions. Coexpression of the AT1 receptor with dopamine receptor interacting protein of 78 kDa, a protein implicated in the cellular routing of the dopamine D1 receptor, increased plasma membrane expression of the AT1 receptor. However, dopamine receptor interacting protein of 78 kDa had no effect on the expression of the AT1-YFFY/A receptor. Taken together, these results suggest that the caveolin-binding-like motif of the AT1 receptor does not promote localization of the receptor to caveolae but rather may act as a docking site for regulatory proteins modulating the routing and the functionality of the receptor.
This article has been cited by other articles:
![]() |
D. J. Dupre, M. Robitaille, M. Richer, N. Ethier, A. M. Mamarbachi, and T. E. Hebert Dopamine Receptor-interacting Protein 78 Acts as a Molecular Chaperone for G{gamma} Subunits before Assembly with Gbeta J. Biol. Chem., May 4, 2007; 282(18): 13703 - 13715. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Syme, L. Zhang, and A. Bisello Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zuo, M. Ushio-Fukai, S. Ikeda, L. Hilenski, N. Patrushev, and R. W. Alexander Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1824 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wruck, H. Funke-Kaiser, T. Pufe, H. Kusserow, M. Menk, J. H. Schefe, M. L. Kruse, M. Stoll, and T. Unger Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Becker, H.-f. Cheng, T. G. Hammond, and R. C. Harris The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties Mol. Pharmacol., February 1, 2004; 65(2): 362 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Wyse, I. A. Prior, H. Qian, I. C. Morrow, S. Nixon, C. Muncke, T. V. Kurzchalia, W. G. Thomas, R. G. Parton, and J. F. Hancock Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane J. Biol. Chem., June 20, 2003; 278(26): 23738 - 23746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |